Study unlocks key to improved outcomes for heart transplant recipients

Loading
43040login-checkStudy unlocks key to improved outcomes for heart transplant recipients

A renewed interest in intravenous ascorbic acid, also known as vitamin C, could improve long-term success outcomes for patients undergoing solid-organ transplant.

Published June 11 in the journal Circulation, the study explores a mechanism for enhancing TET2 (TET methylcytosine dioxygenase 2) enzymatic activity with high dose injections of ascorbic acid. Read the full story in Medical Xpress.

430400login-checkStudy unlocks key to improved outcomes for heart transplant recipients
Loading

Deja una respuesta